Global Disruptive Behaviour Disorders Market Size study, by Type, by Age Group, by Treatment, and Regional Forecasts 2022-2032

Description

Global Disruptive Behavior Disorders (DBD) Market is valued approximately at USD 14.83 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 3.31% over the forecast period 2024-2032. Disruptive Behavior Disorders (DBD) encompass a range of mental health conditions characterized by chronic patterns of disruptive and challenging behaviors, including aggression, defiance, and oppositional conduct. These disorders, which predominantly affect children and adolescents, often result in significant impairment in social, academic, and familial functioning. The increasing prevalence of mental health issues and rising awareness of DBD are significant market drivers, alongside advancements in diagnostic and therapeutic modalities. The growing burden of mental illness, especially among the younger population, underscores the demand for effective treatments and interventions, thereby propelling market growth.

The Global Disruptive Behavior Disorders (DBD) Market is experiencing a notable shift, driven by several key factors such as the rising incidence of mental health disorders and increased societal awareness about the impacts of DBD are leading to greater demand for diagnostic services and therapeutic interventions. The ongoing advancements in treatment options, including digital health solutions and personalized medicine, are opening new avenues for market expansion. The integration of telepsychiatry and mobile health applications is enhancing access to care, particularly in underserved areas, providing a convenient and accessible means of managing DBD. In addition, recent trends highlight the adoption of virtual and augmented reality in therapy, alongside the application of artificial intelligence for improved diagnostic accuracy and risk assessment.

The key region in the Global Disruptive Behavior Disorders (DBD) Market include North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2023, North America dominates the market in terms of revenue, driven by robust healthcare infrastructure, high awareness levels, and substantial investment in mental health. The region benefits from advanced medical technologies, including cutting-edge pharmaceuticals and innovative interventional procedures, which contribute to superior treatment outcomes. The robust healthcare system supports extensive patient access to the latest therapies, and ongoing research efforts drive the development of new and more effective treatment options. Additionally, North America's strong emphasis on preventive care, patient management, and rehabilitation further bolsters its market dominance. Europe follows closely, bolstered by increasing geriatric population and rising healthcare expenditure. The Asia-Pacific region is projected to witness the fastest growth, attributed to improving healthcare systems, increasing awareness about mental health, and growing disposable incomes.

Major market players included in this report are:

Johnson & Johnson
Merck & Co., Inc.
Teva Pharmaceutical Industries Ltd.
Shire PLC
Sanofi S.A.
Takeda Pharmaceutical Company Limited
AstraZeneca PLC
Novartis AG
Otsuka Pharmaceutical Co., Ltd.
Lundbeck A/S
Pfizer Inc.
GlaxoSmithKline PLC
Eli Lilly and Company

The detailed segments and sub-segment of the market are explained below:

By Type:

Attention Deficit Hyperactivity Disorder (ADHD)
Oppositional Defiant Disorder (ODD)
Conduct Disorder (CD)
Intermittent Explosive Disorder (IED)
Disruptive Mood Dysregulation Disorder (DMDD)

By Age Group:

Children
Adolescents
Adults

By Treatment:

Medication
Therapy
Behavioral Therapy
Education and Training
Support Groups

By Severity:

Mild
Moderate
Severe

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Disruptive Behavior Disorders (DBD) Market Executive Summary

1.1. Global Disruptive Behavior Disorders (DBD) Market Size & Forecast (2022- 2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Type
- 1.3.2. By Age Group
- 1.3.3. By Treatment
- 1.3.4. By Severity
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Disruptive Behavior Disorders (DBD) Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Disruptive Behavior Disorders (DBD) Market Dynamics

3.1. Market Drivers
- 3.1.1. Increasing prevalence of mental health disorders
- 3.1.2. Rising awareness of DBD
- 3.1.3. Advancements in diagnostic and treatment options
3.2. Market Challenges
- 3.2.1. High treatment costs
- 3.2.2. Social stigma associated with mental health issues
3.3. Market Opportunities
- 3.3.1. Development of digital health solutions
- 3.3.2. Personalized medicine approaches
- 3.3.3. Research into genetic and biological underpinnings

Chapter 4. Global Disruptive Behavior Disorders (DBD) Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Disruptive Behavior Disorders (DBD) Market Size & Forecasts by Type 2022-2032

5.1. Segment Dashboard
5.2. Global Disruptive Behavior Disorders (DBD) Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 5.2.1. Attention Deficit Hyperactivity Disorder (ADHD)
- 5.2.2. Oppositional Defiant Disorder (ODD)
- 5.2.3. Conduct Disorder (CD)
- 5.2.4. Intermittent Explosive Disorder (IED)
- 5.2.5. Disruptive Mood Dysregulation Disorder (DMDD)

Chapter 6. Global Disruptive Behavior Disorders (DBD) Market Size & Forecasts by Age Group 2022-2032

6.1. Segment Dashboard
6.2. Global Disruptive Behavior Disorders (DBD) Market: Age Group Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 6.2.1. Children
- 6.2.2. Adolescents
- 6.2.3. Adults

Chapter 7. Global Disruptive Behavior Disorders (DBD) Market Size & Forecasts by Treatment 2022-2032

7.1. Segment Dashboard
7.2. Global Disruptive Behavior Disorders (DBD) Market: Treatment Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 7.2.1. Medication
- 7.2.2. Therapy
- 7.2.3. Behavioral Therapy
- 7.2.4. Education and Training
- 7.2.5. Support Groups

Chapter 8. Global Disruptive Behavior Disorders (DBD) Market Size & Forecasts by Severity 2022-2032

8.1. Segment Dashboard
8.2. Global Disruptive Behavior Disorders (DBD) Market: Severity Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 8.2.1. Mild
- 8.2.2. Moderate
- 8.2.3. Severe

Chapter 9. Global Disruptive Behavior Disorders (DBD) Market Size & Forecasts by Region 2022-2032

9.1. North America Disruptive Behavior Disorders (DBD) Market
- 9.1.1. U.S. Disruptive Behavior Disorders (DBD) Market
  - 9.1.1.1. Type breakdown size & forecasts, 2022-2032
  - 9.1.1.2. Age Group breakdown size & forecasts, 2022-2032
  - 9.1.1.3. Treatment breakdown size & forecasts, 2022-2032
  - 9.1.1.4. Severity breakdown size & forecasts, 2022-2032
- 9.1.2. Canada Disruptive Behavior Disorders (DBD) Market
  - 9.1.2.1. Type breakdown size & forecasts, 2022-2032
  - 9.1.2.2. Age Group breakdown size & forecasts, 2022-2032
  - 9.1.2.3. Treatment breakdown size & forecasts, 2022-2032
  - 9.1.2.4. Severity breakdown size & forecasts, 2022-2032
9.2. Europe Disruptive Behavior Disorders (DBD) Market
- 9.2.1. U.K. Disruptive Behavior Disorders (DBD) Market
- 9.2.2. Germany Disruptive Behavior Disorders (DBD) Market
- 9.2.3. France Disruptive Behavior Disorders (DBD) Market
- 9.2.4. Spain Disruptive Behavior Disorders (DBD) Market
- 9.2.5. Italy Disruptive Behavior Disorders (DBD) Market
- 9.2.6. Rest of Europe Disruptive Behavior Disorders (DBD) Market
9.3. Asia-Pacific Disruptive Behavior Disorders (DBD) Market
- 9.3.1. China Disruptive Behavior Disorders (DBD) Market
- 9.3.2. India Disruptive Behavior Disorders (DBD) Market
- 9.3.3. Japan Disruptive Behavior Disorders (DBD) Market
- 9.3.4. Australia Disruptive Behavior Disorders (DBD) Market
- 9.3.5. South Korea Disruptive Behavior Disorders (DBD) Market
- 9.3.6. Rest of Asia Pacific Disruptive Behavior Disorders (DBD) Market
9.4. Latin America Disruptive Behavior Disorders (DBD) Market
- 9.4.1. Brazil Disruptive Behavior Disorders (DBD) Market
- 9.4.2. Mexico Disruptive Behavior Disorders (DBD) Market
- 9.4.3. Rest of Latin America Disruptive Behavior Disorders (DBD) Market
9.5. Middle East & Africa Disruptive Behavior Disorders (DBD) Market
- 9.5.1. Saudi Arabia Disruptive Behavior Disorders (DBD) Market
- 9.5.2. South Africa Disruptive Behavior Disorders (DBD) Market
- 9.5.3. Rest of Middle East & Africa Disruptive Behavior Disorders (DBD) Market

Chapter 10. Competitive Intelligence

10.1. Key Company SWOT Analysis
10.2. Top Market Strategies
10.3. Company Profiles
- 10.3.1. Shire
  - 10.3.1.1. Key Information
  - 10.3.1.2. Overview
  - 10.3.1.3. Financial (Subject to Data Availability)
  - 10.3.1.4. Product Summary
  - 10.3.1.5. Market Strategies
- 10.3.2. Sanofi
- 10.3.3. Takeda
- 10.3.4. AstraZeneca
- 10.3.5. Novartis
- 10.3.6. Otsuka
- 10.3.7. Lundbeck
- 10.3.8. Pfizer
- 10.3.9. GlaxoSmithKline
- 10.3.10. Eli Lilly
- 10.3.11. Johnson & Johnson
- 10.3.12. Merck
- 10.3.13. Teva

Chapter 11. Research Process

11.1. Research Process
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
11.2. Research Attributes